Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.
2.

Development and evaluation of a spatial decision support system for malaria elimination in Bhutan.

Wangdi K, Banwell C, Gatton ML, Kelly GC, Namgay R, Clements AC.

Malar J. 2016 Mar 22;15:180. doi: 10.1186/s12936-016-1235-4.

3.

Pan-Plasmodium band sensitivity for Plasmodium falciparum detection in combination malaria rapid diagnostic tests and implications for clinical management.

Gatton ML, Rees-Channer RR, Glenn J, Barnwell JW, Cheng Q, Chiodini PL, Incardona S, González IJ, Cunningham J.

Malar J. 2015 Mar 18;14:115. doi: 10.1186/s12936-015-0629-z.

4.

A simulation model of the within-host dynamics of Plasmodium vivax infection.

Kerlin DH, Gatton ML.

Malar J. 2015 Feb 5;14:51. doi: 10.1186/s12936-015-0580-z.

5.

Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors.

Cheng Q, Cunningham J, Gatton ML.

PLoS Negl Trop Dis. 2015 Jan 8;9(1):e3413. doi: 10.1371/journal.pntd.0003413. eCollection 2015 Jan. Review.

6.

Circulating antibodies against Plasmodium falciparum histidine-rich proteins 2 interfere with antigen detection by rapid diagnostic tests.

Ho MF, Baker J, Lee N, Luchavez J, Ariey F, Nhem S, Oyibo W, Bell D, González I, Chiodini P, Gatton ML, Cheng Q, McCarthy JS.

Malar J. 2014 Dec 6;13:480. doi: 10.1186/1475-2875-13-480.

7.

Prevalence of asymptomatic malaria and bed net ownership and use in Bhutan, 2013: a country earmarked for malaria elimination.

Wangdi K, Gatton ML, Kelly GC, Clements AC.

Malar J. 2014 Sep 4;13:352. doi: 10.1186/1475-2875-13-352.

8.

Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting.

Cheng Q, Gatton ML, Barnwell J, Chiodini P, McCarthy J, Bell D, Cunningham J.

Malar J. 2014 Jul 22;13:283. doi: 10.1186/1475-2875-13-283. Review.

9.

Fatty acid synthesis and pyruvate metabolism pathways remain active in dihydroartemisinin-induced dormant ring stages of Plasmodium falciparum.

Chen N, LaCrue AN, Teuscher F, Waters NC, Gatton ML, Kyle DE, Cheng Q.

Antimicrob Agents Chemother. 2014 Aug;58(8):4773-81. doi: 10.1128/AAC.02647-14. Epub 2014 Jun 9.

10.

Recasting the theory of mosquito-borne pathogen transmission dynamics and control.

Smith DL, Perkins TA, Reiner RC Jr, Barker CM, Niu T, Chaves LF, Ellis AM, George DB, Le Menach A, Pulliam JR, Bisanzio D, Buckee C, Chiyaka C, Cummings DA, Garcia AJ, Gatton ML, Gething PW, Hartley DM, Johnston G, Klein EY, Michael E, Lloyd AL, Pigott DM, Reisen WK, Ruktanonchai N, Singh BK, Stoller J, Tatem AJ, Kitron U, Godfray HC, Cohen JM, Hay SI, Scott TW.

Trans R Soc Trop Med Hyg. 2014 Apr;108(4):185-97. doi: 10.1093/trstmh/tru026. Epub 2014 Mar 3.

11.

The importance of mosquito behavioural adaptations to malaria control in Africa.

Gatton ML, Chitnis N, Churcher T, Donnelly MJ, Ghani AC, Godfray HC, Gould F, Hastings I, Marshall J, Ranson H, Rowland M, Shaman J, Lindsay SW.

Evolution. 2013 Apr;67(4):1218-30. doi: 10.1111/evo.12063. Epub 2013 Feb 15. Review.

12.

Preferential invasion by Plasmodium merozoites and the self-regulation of parasite burden.

Kerlin DH, Gatton ML.

PLoS One. 2013;8(2):e57434. doi: 10.1371/journal.pone.0057434. Epub 2013 Feb 27.

13.

Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy?

Cheng Q, Kyle DE, Gatton ML.

Int J Parasitol Drugs Drug Resist. 2012 Dec 1;2:249-255. Epub 2012 Jan 27.

14.

A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970-2010.

Reiner RC Jr, Perkins TA, Barker CM, Niu T, Chaves LF, Ellis AM, George DB, Le Menach A, Pulliam JR, Bisanzio D, Buckee C, Chiyaka C, Cummings DA, Garcia AJ, Gatton ML, Gething PW, Hartley DM, Johnston G, Klein EY, Michael E, Lindsay SW, Lloyd AL, Pigott DM, Reisen WK, Ruktanonchai N, Singh BK, Tatem AJ, Kitron U, Hay SI, Scott TW, Smith DL.

J R Soc Interface. 2013 Feb 13;10(81):20120921. doi: 10.1098/rsif.2012.0921. Print 2013 Apr 6. Review.

15.

An analytical method for assessing stage-specific drug activity in Plasmodium vivax malaria: implications for ex vivo drug susceptibility testing.

Kerlin DH, Boyce K, Marfurt J, Simpson JA, Kenangalem E, Cheng Q, Price RN, Gatton ML.

PLoS Negl Trop Dis. 2012;6(8):e1772. doi: 10.1371/journal.pntd.0001772. Epub 2012 Aug 7.

16.
17.

Identification of optimal epitopes for Plasmodium falciparum rapid diagnostic tests that target histidine-rich proteins 2 and 3.

Lee N, Gatton ML, Pelecanos A, Bubb M, Gonzalez I, Bell D, Cheng Q, McCarthy JS.

J Clin Microbiol. 2012 Apr;50(4):1397-405. doi: 10.1128/JCM.06533-11. Epub 2012 Jan 18.

18.

Phenotypic changes in artemisinin-resistant Plasmodium falciparum lines in vitro: evidence for decreased sensitivity to dormancy and growth inhibition.

Teuscher F, Chen N, Kyle DE, Gatton ML, Cheng Q.

Antimicrob Agents Chemother. 2012 Jan;56(1):428-31. doi: 10.1128/AAC.05456-11. Epub 2011 Oct 10.

19.

Transcription and expression of Plasmodium falciparum histidine-rich proteins in different stages and strains: implications for rapid diagnostic tests.

Baker J, Gatton ML, Peters J, Ho MF, McCarthy JS, Cheng Q.

PLoS One. 2011;6(7):e22593. doi: 10.1371/journal.pone.0022593. Epub 2011 Jul 22.

20.

An improved method for undertaking limiting dilution assays for in vitro cloning of Plasmodium falciparum parasites.

Butterworth AS, Robertson AJ, Ho MF, Gatton ML, McCarthy JS, Trenholme KR.

Malar J. 2011 Apr 18;10:95. doi: 10.1186/1475-2875-10-95.

Supplemental Content

Loading ...
Support Center